GnRH analogue in assessing chronic pelvic pain in women with residual ovaries

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 2, 1996, Pages 150-153

  Carey, Marcus P ^a,b   Slack, Mark C ^a  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN DERIVATIVE; GOSERELIN;

ABDOMINAL PAIN; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; OVARY DISEASE; OVARY FUNCTION; PRIORITY JOURNAL;

ADULT; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GOSERELIN; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIAN DISEASES; OVARIECTOMY; PAIN, POSTOPERATIVE; PELVIC PAIN;

EID: 0030044231     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09667.x     Document Type: Article

References (9)

1. Christ JE, Lotze EC. The residual ovary syndrome. Obstet Gynecol 1975; 46: 551–556.
2. Bukovsky I, Liftshitz Y, Langer R et al. Ovarian residual syndrome. Surg Gynecol Obstet 1988; 167: 132–134.
3. Donnelly RJ, Milsted RAV. Zoladex studies in prostatic and breast cancer. In: Vickery BH, Nestor JJ, editors. LHRH and its Analogues. Contraceptive and Therapeutic Applications. Amsterdam : Elsevier Science Publishers BV, 1987: 397–407.
4. Fraser HM. LHRH analogues: their clinical physiology and delivery systems. In: Healy O, editor Clinical Obstetrics and Gynaecology Vol 2. London : Bailliere Tindall, 1988: 639–658.
5. Steege JF, Stout AL, Somkuti SG. Chronic pelvic pain in women: toward an integrative model. Obstet Gynecol Surv 1993; 48: 95–110.
6. Grogan RH. Reappraisal of residual ovaries. Am J Obstet Gynecol 1967; 97: 124–129.
7. Siddall-Allum J, Rae T, Rogers V et al. Chronic pelvic pain caused by residual ovaries and ovarian remnants. Br J Obstet Gynaecol 1994; 101: 979–985.
8. Johnson AG. Surgery as a placebo. Lancet 1994; 344: 1140–1142.
9. Matta WH, Stabile I, Shaw RW, Campbell S. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotrophin-releasing hormone agonist Buserelin. Fertil Steril 1988; 49: 1038–1085.